Skip to main content
. 2021 Jul 1;13(7):e16095. doi: 10.7759/cureus.16095

Table 1. Main Treatments of Narcolepsy .

EDS: excessive daytime sleepiness

Drugs Dosage Indication Mechanism of action
Modafinil 100 - 400 mg First-line treatment for EDS Promotes wakefulness by stimulating histamine (HA), norepinephrine (NE), serotonin (5-HT), dopamine (DA), and orexin systems in the brain [12].
Solriamfetol 75 - 150 mg First-line treatment for EDS Possible increased activity as a dopamine and norepinephrine reuptake inhibitor [13].
Pitolisant 4.5 - 36.0 mg First-line treatment for EDS and cataplexy H3 receptor antagonist/inverse agonist [2].
Methylphenidate 10 - 60 mg Second-line treatment for EDS Non-competitively blocks the reuptake of dopamine and noradrenaline into the terminal by blocking dopamine transporter (DAT) and noradrenaline transporter (NAT), increasing levels of dopamine and noradrenaline in the synaptic cleft [14].
Amphetamines Amphetamine mixed salts: 10 - 60 mg; Dexamphetamine: 10 - 60 mg Second-line treatment for EDS Elevates extracellular dopamine (DA) and prolonging DA receptor signaling in the striatum [15].